CD44 and cancer: Surviving cells after 12 Gy were allowed to regrow and were subsequently used after 4–6 weeks of culture as illustrated in Figure 4A. The cancer stem cell markers CD44 and CD133, and the normal stem cell markers Sox2, Oct 4, and Nanog were all increased at this time point (Figure 4D).